Abbott continuous glucose monitor gets FDA go-ahead
This article was originally published in The Gray Sheet
Executive Summary
Long-awaited PMA approval of Abbott's FreeStyle Navigator sets the stage for a second quarter launch of the device, the company says. Abbott is the third firm to gain FDA approval for a CGM system after Medtronic (Guardian and Paradigm Real-Time systems) and DexCom (Seven). Navigator, approved March 12, consists of a sensor inserted just under the skin of the arm or abdomen, which can be worn for five days, and a pager-sized receiver that displays glucose information every minute and triggers an audible or vibrating alarm if glucose levels become too high or low. DexCom's sensor can be worn for seven days, and Medtronic's for three. Navigator has a longer 10-hour start-up initialization time versus two hours for the other systems. The market uptake of CGM devices, which are used as adjuncts to finger stick testing, has been slower than anticipated largely due to poor reimbursement, according to analysts (1"The Gray Sheet" Nov. 26, 2007, p. 6)
You may also be interested in...
Smiths Medical to market Freestyle Navigator
Manufacturer of the Deltec Cozmo insulin pump will promote and distribute Abbott's FreeStyle Navigator continuous glucose monitoring system under a non-exclusive U.S. distribution deal. Announced April 22, the pact will supplement Abbott's own marketing efforts. The FreeStyle Navigator was approved March 12 (1"The Gray Sheet" March 17, 2008, In Brief)
Continuous Glucose Monitor Market Remains In Abbott’s Sights
Abbott says an FDA inspection of one third-party supplier is the only remaining barrier to PMA approval for its long-delayed Freestyle Navigator continuous glucose monitor
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.